These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. Nobili V; Cutrera R; Liccardo D; Pavone M; Devito R; Giorgio V; Verrillo E; Baviera G; Musso G Am J Respir Crit Care Med; 2014 Jan; 189(1):66-76. PubMed ID: 24256086 [TBL] [Abstract][Full Text] [Related]
4. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. Aron-Wisnewsky J; Minville C; Tordjman J; Lévy P; Bouillot JL; Basdevant A; Bedossa P; Clément K; Pépin JL J Hepatol; 2012 Jan; 56(1):225-33. PubMed ID: 21703181 [TBL] [Abstract][Full Text] [Related]
5. Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia. Türkay C; Ozol D; Kasapoğlu B; Kirbas I; Yıldırım Z; Yiğitoğlu R Respir Care; 2012 Feb; 57(2):244-9. PubMed ID: 21762556 [TBL] [Abstract][Full Text] [Related]
6. Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2/NFκB signaling pathway. Zhang H; Zhou L; Zhou Y; Wang L; Jiang W; Liu L; Yue S; Zheng P; Liu H Life Sci; 2021 Nov; 285():119963. PubMed ID: 34536498 [TBL] [Abstract][Full Text] [Related]
7. The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease. Arias-Loste MT; Fábrega E; López-Hoyos M; Crespo J Biomed Res Int; 2015; 2015():319745. PubMed ID: 26491664 [TBL] [Abstract][Full Text] [Related]
8. Chronic intermittent hypoxia promotes early intrahepatic endothelial impairment in rats with nonalcoholic fatty liver disease. Hernández-Bustabad A; Morales-Arraez D; González-Paredes FJ; Abrante B; Díaz-Flores F; Abreu-González P; de la Barreda R; Quintero E; Hernández-Guerra M Am J Physiol Gastrointest Liver Physiol; 2022 Oct; 323(4):G362-G374. PubMed ID: 35916415 [TBL] [Abstract][Full Text] [Related]
12. Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children. Sundaram SS; Halbower AC; Klawitter J; Pan Z; Robbins K; Capocelli KE; Sokol RJ J Pediatr; 2018 Jul; 198():67-75.e1. PubMed ID: 29752170 [TBL] [Abstract][Full Text] [Related]
13. Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. Musso G; Cassader M; Olivetti C; Rosina F; Carbone G; Gambino R Obes Rev; 2013 May; 14(5):417-31. PubMed ID: 23387384 [TBL] [Abstract][Full Text] [Related]
14. The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity. Benotti P; Wood GC; Argyropoulos G; Pack A; Keenan BT; Gao X; Gerhard G; Still C Obesity (Silver Spring); 2016 Apr; 24(4):871-7. PubMed ID: 26880657 [TBL] [Abstract][Full Text] [Related]
15. Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease. Mesarwi OA; Loomba R; Malhotra A Am J Respir Crit Care Med; 2019 Apr; 199(7):830-841. PubMed ID: 30422676 [TBL] [Abstract][Full Text] [Related]
16. Obstructive Sleep Apnea Syndrome and Metabolic Diseases. Li M; Li X; Lu Y Endocrinology; 2018 Jul; 159(7):2670-2675. PubMed ID: 29788220 [TBL] [Abstract][Full Text] [Related]
17. Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis. Sookoian S; Pirola CJ Obes Surg; 2013 Nov; 23(11):1815-25. PubMed ID: 23740153 [TBL] [Abstract][Full Text] [Related]
18. Obstructive Sleep Apnea and the Liver. Parikh MP; Gupta NM; McCullough AJ Clin Liver Dis; 2019 May; 23(2):363-382. PubMed ID: 30947882 [TBL] [Abstract][Full Text] [Related]
19. Adipose tissue is influenced by hypoxia of obstructive sleep apnea syndrome independent of obesity. Thorn CE; Knight B; Pastel E; McCulloch LJ; Patel B; Shore AC; Kos K Diabetes Metab; 2017 Jun; 43(3):240-247. PubMed ID: 28131740 [TBL] [Abstract][Full Text] [Related]
20. Altered gut-liver axis and hepatic adiponectin expression in OSAS: novel mediators of liver injury in paediatric non-alcoholic fatty liver. Nobili V; Alisi A; Cutrera R; Carpino G; De Stefanis C; D'Oria V; De Vito R; Cucchiara S; Gaudio E; Musso G Thorax; 2015 Aug; 70(8):769-81. PubMed ID: 26069285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]